Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemours Company (NY: CC )

18.89 -0.18 (-0.94%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
CHEMOURS (NYSE: CC): Kaplan Fox &amp; Kilsheimer LLP Investigates The Chemours Company for Potential Securities Law Violations and Encourages Investors to Contact the Firm
NEW YORK, NY - (NewMediaWire) - March 14, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via TheNewswire.com
CHEMOURS (NYSE: CC): Kaplan Fox & Kilsheimer LLP is Investigating The Chemours Company for Possible Violations of Federal Securities Laws
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
CHEMOURS (NYSE: CC): Kaplan Fox &amp; Kilsheimer LLP is Investigating The Chemours Company for Possible Violations of Federal Securities Laws
NEW YORK, NY - (NewMediaWire) - March 13, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via TheNewswire.com
CC ALERT: Kessler Topaz Meltzer & Check, LLP is Investigating The Chemours Company (CC) for Possible Violations of Federal Securities Laws
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Why Chemours Stock Soared Today
Chemours concluded an internal review, determining its former CEO, CFO, and company controller violated its code of ethics. 
Via The Motley Fool
ROSEN, A RANKED AND LEADING FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 09, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via TheNewswire.com
Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of The Chemours Company (CC) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
CC LOSS ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 07, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via NewMediaWire
CC LOSS ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 07, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via TheNewswire.com
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of The Chemours Company (CC) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. 
Via Benzinga
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Chemours Provides Update on Internal Review
From The Chemours Company
Via Business Wire
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours Co
NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via NewMediaWire
Topics Fraud
Exposures Legal
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours Co
NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via TheNewswire.com
Topics Fraud
Exposures Legal
CC INVESTIGATION ALERT: Kirby McInerney LLP Continues Investigation on Behalf of The Chemours Company Investors
From Kirby McInerney LLP
Via Business Wire
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Renowned Litigation Firm Labaton Keller Sucharow LLP is Investigating The Chemours Company for Securities Violations and Encourages Investors to Contact the Firm
From Labaton Keller Sucharow LLP
Via Business Wire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via NewMediaWire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via TheNewswire.com
Renowned Litigation Firm Labaton Keller Sucharow LLP is Investigating The Chemours Company for Securities Violations and Encourages Investors to Contact the Firm
From Labaton Keller Sucharow
Via Business Wire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours... 
Via TheNewswire.com
Analyst Finds It Difficult To Make Numeric Assumptions For Chemours: Here's Why
BMO analyst downgrades Chemours to Underperform, citing delayed filings, management changes, and difficulty in making earnings assumptions. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.